Clinical Management of a Pandrug-Resistant OXA-48 Klebsiella pneumoniae Infection in the Pediatric Intensive Care Unit.

MLA

Havan, Merve, et al. “Clinical Management of a Pandrug-Resistant OXA-48 Klebsiella Pneumoniae Infection in the Pediatric Intensive Care Unit.” Microbial Drug Resistance (Larchmont, N.Y.), vol. 29, no. 6, June 2023, pp. 256–62. EBSCOhost, https://doi.org/10.1089/mdr.2022.0247.

APA

Havan, M., Kendirli, T., Parlar, Ö. T., Özcan, S., Yahşi, A., Erat, T., Öcal, D., Guriz, H., Özdemir, H., Karahan, Z. C., Çiftci, E., & İnce, E. (2023). Clinical Management of a Pandrug-Resistant OXA-48 Klebsiella pneumoniae Infection in the Pediatric Intensive Care Unit. Microbial Drug Resistance (Larchmont, N.Y.), 29(6), 256–262. https://doi.org/10.1089/mdr.2022.0247

Chicago

Havan, Merve, Tanıl Kendirli, Özgün Tutku Parlar, Serhan Özcan, Aysun Yahşi, Tuğba Erat, Duygu Öcal, et al. 2023. “Clinical Management of a Pandrug-Resistant OXA-48 Klebsiella Pneumoniae Infection in the Pediatric Intensive Care Unit.” Microbial Drug Resistance (Larchmont, N.Y.) 29 (6): 256–62. doi:10.1089/mdr.2022.0247.